Antibody-drug Conjugates Market Size Growing at 3% CAGR to hit USD 3262.1 Million by 2026


(MENAFN- America News Hour) Market
Study Report adds new research on Antibody-drug Conjugates market, which is a
detailed analysis of this business space inclusive of the trends, competitive
landscape, and the market size. Encompassing one or more parameters among
product analysis, application potential, and the regional growth landscape, Antibody-drug
Conjugates market also includes an in-depth study of the industrys competitive
scenario.


The global Antibody-drug Conjugates market is valued at 2646.2 million US$ in 2020 is expected to reach 3262.1 million US$ by the end of 2026, growing at a CAGR of 3.0% during 2021-2026.


The
major players in global Antibody-drug Conjugates market include:


    ImmunoGen


    Seattle Genetics


    Roche


    Takeda


Request
a sample of this premium report at
https://www.marketstudyreport.com/request-a-sample/2416252?utm_source=marketwatch.com & utm_medium=Abhijeet


Antibody
Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to
biologically active drugs by chemical linkers with labile bonds. By combining
the unique targeting of mAbs with the cancer-killing ability of cytotoxic
drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.


North
America ranks the top in terms of global market size of Antibody Drug
Conjugate, it consists of 59.12% of the international market in 2016. Europe
comes the second, with 27.70% of the global market. Asia Pacific consists of
6.54%of the Antibody Drug Conjugate market in the same year.


This
report focuses on Antibody-drug Conjugates volume and value at the global
level, regional level and company level. From a global perspective, this report
represents overall Antibody-drug Conjugates market size by analysing historical
data and future prospect. Regionally, this report focuses on several key
regions: North America, Europe, China and Japan etc.


Market
Segment Analysis


The
research report includes specific segments by Type and by Application. This
study provides information about the sales and revenue during the historic and
forecasted period of 2015 to 2026. Understanding the segments helps in
identifying the importance of different factors that aid the market growth.


Request
a discount on standard prices of this premium report at
https://www.marketstudyreport.com/check-for-discount/2416252?utm_source=marketwatch.com & utm_medium=Abhijeet
 


Segment
by Type, the Antibody-drug Conjugates market is segmented into


    Adcetris


    Kadcyla


Segment
by Application


    Breast Cancer


    Lymphoma


 Global Antibody-drug Conjugates Market:
Regional Analysis


The
Antibody-drug Conjugates market is analysed and market size information is
provided by regions (countries). The report includes country-wise and
region-wise market size for the period 2015-2026. It also includes market size
and forecast by Type and by Application segment in terms of sales and revenue
for the period 2015-2026.


Global
Antibody-drug Conjugates Market: Competitive Analysis


This
section of the report identifies various key manufacturers of the market. It
helps the reader understand the strategies and collaborations that players are
focusing on combat competition in the market. The comprehensive report provides
a significant microscopic look at the market. The reader can identify the
footprints of the manufacturers by knowing about the global revenue of
manufacturers, the global price of manufacturers, and sales by manufacturers
during the forecast period of 2015 to 2019.


Table of Contents


1
Antibody-drug Conjugates Market Overview


    1.1 Product Overview and Scope of
Antibody-drug Conjugates


    1.2 Antibody-drug Conjugates Segment by
Type


    1.3 Antibody-drug Conjugates Segment by
Application


    1.4 Global Antibody-drug Conjugates Market
Size Estimates and Forecasts


2
Global Antibody-drug Conjugates Market Competition by Manufacturers


    2.1 Global Antibody-drug Conjugates Sales
Market Share by Manufacturers (2015-2020)


    2.2 Global Antibody-drug Conjugates Revenue
Share by Manufacturers (2015-2020)


    2.3 Global Antibody-drug Conjugates Average
Price by Manufacturers (2015-2020)


    2.4 Manufacturers Antibody-drug Conjugates
Manufacturing Sites, Area Served, Product Type


    2.5
Antibody-drug Conjugates Market Competitive Situation and Trends


    2.6 Manufacturers Mergers &
Acquisitions, Expansion Plans


    2.7 Primary Interviews with Key
Antibody-drug Conjugates Players (Opinion Leaders)


3
Antibody-drug Conjugates Retrospective Market Scenario by Region


4
Global Antibody-drug Conjugates Historic Market Analysis by Type


5
Global Antibody-drug Conjugates Historic Market Analysis by Application


6
Company Profiles and Key Figures in Antibody-drug Conjugates Business


    6.1 ImmunoGen


    6.2 Seattle Genetics


    6.3 Roche


    6.4 Takeda


7
Antibody-drug Conjugates Manufacturing Cost Analysis


8
Marketing Channel, Distributors and Customers


9
Market Dynamics


10
Global Market Forecast


11
Research Finding and Conclusion


12
Methodology and Data Source


12.1
Methodology/Research Approach


12.1.1
Research Programs/Design


12.1.2
Market Size Estimation


12.1.3
Market Breakdown and Data Triangulation


12.2
Data Source


12.2.1
Secondary Sources


12.2.2
Primary Sources


12.3
Author List


12.4
Disclaimer


buying decision on this premium report https://www.marketstudyreport.com/enquiry-before-buying/2416252?utm_source=marketwatch.com & utm_medium=Abhijeet
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog


Market Study Report LLC

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

MENAFN06012020007010068ID1099514233

-MENAFN06012020007010068ID1099514233-->


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.